quinoxalines has been researched along with cholecystokinin in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pinnock, RD | 1 |
| Lanza, M; Makovec, F | 1 |
| Andresen, MC; Appleyard, SM; Bailey, TW; Doyle, MW; Jin, YH; Low, MJ; Smart, JL | 1 |
| Sartor, DM; Verberne, AJ | 1 |
| Andresen, MC; Appleyard, SM; Kobayashi, K; Low, MJ; Marks, D; Okano, H | 1 |
| Brunner, J; Chen, K; Soltesz, I; Szabadics, J; Varga, C | 1 |
| Chen, X; Feng, J; Guo, YP; He, J; Li, X; Liu, CH; Sun, W; Wang, H; Yang, Z; Yu, K; Zhang, Z | 1 |
| Althammer, F; Busnelli, M; Chao, MV; Charlet, A; Chavant, V; Chini, B; Ciobanu, AC; da Silva Gouveia, M; Eliava, M; Froemke, RC; Giese, G; Goumon, Y; Grinevich, V; Gruber, T; Knobloch-Bollmann, HS; Kuner, R; Melchior, M; Mitre, M; Petit-Demoulière, N; Poisbeau, P; Roth, LC; Seeburg, PH; Sprengel, R; Stoop, R; Tan, LL; Tang, Y; Triana Del Rio, R; Wahis, J | 1 |
8 other study(ies) available for quinoxalines and cholecystokinin
| Article | Year |
|---|---|
Activation of kappa-opioid receptors depresses electrically evoked excitatory postsynaptic potentials on 5-HT-sensitive neurones in the rat dorsal raphé nucleus in vitro.
Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; Afferent Pathways; Animals; Benzofurans; Bicuculline; Bombesin; Cholecystokinin; Electric Stimulation; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Evoked Potentials; Glutamates; Glutamic Acid; In Vitro Techniques; Kynurenic Acid; N-Methylaspartate; Naloxone; Naltrexone; Neurons; Picrotoxin; Prazosin; Pyrrolidines; Quinoxalines; Raphe Nuclei; Rats; Receptors, Opioid; Receptors, Opioid, kappa; Receptors, Opioid, mu; Serotonin; Synapses; Tetrodotoxin | 1992 |
Cholecystokinin (CCK) increases GABA release in the rat anterior nucleus accumbens via CCK(B) receptors located on glutamatergic interneurons.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Cholecystokinin; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; gamma-Aminobutyric Acid; Glutamic Acid; Interneurons; Male; Microdialysis; N-Methylaspartate; Nucleus Accumbens; Potassium; Quinoxalines; Rats; Rats, Wistar; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Sincalide; Stimulation, Chemical; Tetrodotoxin | 2000 |
Proopiomelanocortin neurons in nucleus tractus solitarius are activated by visceral afferents: regulation by cholecystokinin and opioids.
Topics: Animals; Cell Count; Cholecystokinin; Dose-Response Relationship, Drug; Drug Interactions; Electric Stimulation; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, Methionine; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Gene Expression Regulation; Green Fluorescent Proteins; Hormone Antagonists; Immunohistochemistry; In Vitro Techniques; Membrane Potentials; Mice; Mice, Transgenic; Narcotics; Neurons; Patch-Clamp Techniques; Pro-Opiomelanocortin; Proglumide; Proto-Oncogene Proteins c-fos; Quinoxalines; Solitary Nucleus; Time Factors; Visceral Afferents | 2005 |
The role of NMDA and non-NMDA receptors in the NTS in mediating three distinct sympathoinhibitory reflexes.
Topics: 2-Amino-5-phosphonovalerate; Animals; Biguanides; Blood Pressure; Cholecystokinin; GABA Agonists; Heart Rate; Kynurenic Acid; Male; Muscimol; Phenylephrine; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Receptors, Kainic Acid; Receptors, N-Methyl-D-Aspartate; Reflex; Solitary Nucleus; Synaptic Transmission | 2007 |
Visceral afferents directly activate catecholamine neurons in the solitary tract nucleus.
Topics: 4-Aminopyridine; Afferent Pathways; Analysis of Variance; Animals; Catecholamines; Cholecystokinin; Dose-Response Relationship, Radiation; Electric Stimulation; Excitatory Amino Acid Antagonists; Green Fluorescent Proteins; In Vitro Techniques; Membrane Potentials; Mice; Mice, Transgenic; Neurons; Patch-Clamp Techniques; Potassium Channel Blockers; Pyridazines; Quinoxalines; Solitary Nucleus; Tyrosine 3-Monooxygenase | 2007 |
Granule cells in the CA3 area.
Topics: Animals; Animals, Newborn; CA3 Region, Hippocampal; Calbindins; Cannabinoid Receptor Modulators; Cholecystokinin; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; gamma-Aminobutyric Acid; Homeodomain Proteins; In Vitro Techniques; Lysine; Membrane Potentials; Microscopy, Electron, Transmission; Nerve Net; Neurons; Neuropeptide Y; Patch-Clamp Techniques; Quinoxalines; Rats; Rats, Wistar; S100 Calcium Binding Protein G; Synapses; Tumor Suppressor Proteins | 2010 |
Cholecystokinin from the entorhinal cortex enables neural plasticity in the auditory cortex.
Topics: Animals; Auditory Cortex; Cholecystokinin; Entorhinal Cortex; Guinea Pigs; Hippocampus; Membrane Potentials; Neuronal Plasticity; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptor, Cholecystokinin B | 2014 |
A New Population of Parvocellular Oxytocin Neurons Controlling Magnocellular Neuron Activity and Inflammatory Pain Processing.
Topics: Action Potentials; Animals; Cholecystokinin; Disease Models, Animal; Excitatory Amino Acid Antagonists; Gene Expression Regulation; Inflammation; Neural Pathways; Neuralgia; Neurons; Oxytocin; Paraventricular Hypothalamic Nucleus; Quinoxalines; Rats; Rats, Wistar; Receptors, Oxytocin; Spinal Cord; Supraoptic Nucleus; Transduction, Genetic; Vasopressins; Vesicular Glutamate Transport Protein 2 | 2016 |